H–cadherin, a novel cadherin with growth inhibitory functions and diminished expression in human breast cancer
- 1 July 1996
- journal article
- Published by Springer Nature in Nature Medicine
- Vol. 2 (7) , 776-782
- https://doi.org/10.1038/nm0796-776
Abstract
A newly identified gene, H–cadherin, is reported. H–cadherin encodes a protein related to the cadherin superfamily of cell adhesion molecules, and its expression is shown to be significantly reduced in human breast carcinoma cell lines and breast cancer specimens. H–cadherin was localized to chromosome 16q24 and is highly expressed in the heart. Introduction of H–cadherin cDNA markedly diminished tumor cell growth and resulted in a significant change from invasive morphology to a normal cell–like morphology in the Matrigel outgrowth assay. These studies indicate that downregulation of H–cadherin may be frequent in the breast malignant progression and suggest that it may have prognostic value as a marker for breast cancer development.Keywords
This publication has 37 references indexed in Scilit:
- Prevention of breast tumour development in vivo by downregulation of the p185neureceptorNature Medicine, 1995
- Cancer: the rise of the genetic paradigmGenes & Development, 1995
- WAF1, a potential mediator of p53 tumor suppressionCell, 1993
- APC mutations occur early during colorectal tumorigenesisNature, 1992
- Tumor Suppressor GenesScience, 1991
- The p53 tumour suppressor geneNature, 1991
- The candidate Wilms' tumour gene is involved in genitourinary developmentNature, 1990
- Identification of a Chromosome 18q Gene that Is Altered in Colorectal CancersScience, 1990
- Human Breast Cancer: Correlation of Relapse and Survival with Amplification of the HER-2/ neu OncogeneScience, 1987
- A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcomaNature, 1986